Medium materiality6/10
H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
Why it may matterVerify against the original reporting
Reaffirmed Buy with meaningful upside versus current price.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Reaffirmed Buy with meaningful upside versus current price.
What happened, with direct paths to the underlying reporting
Opus Genetics target $8; posted price $2.78; Buy rating reiterated.
Target: $8
Posted price: $2.78
Analyst firm: H.C. Wainwright
Analyst: Matthew Caufield
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.